LACOSAMIDE INJECTION, USP
Google image searchProduct monograph
Active ingredient
lacosamide, 10 MG/ML
DIN: 02541343
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Schedule: Prescription
Company: HIKMA CANADA LIMITED
Date: 17-MAY-2024
ATC:
- N03 — ANTIEPILEPTICS (ATC, ATC/DDD, )
- N03A — ANTIEPILEPTICS (ATC, ATC/DDD)
- N03AX — Other antiepileptics (ATC, ATC/DDD)
- N03AX18 — LACOSAMIDE (ATC/DDD)
Reference brand drug: Vimpat
Pharmaceutical standard: USP